SCHEDULE 14A

Company

Insight Molecular Diagnostics Inc.

Filed

April 29, 2016

Period of Report

June 9, 2016

Accession Number

0001567619-16-002255

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →